GF Fund Management
MENS icon

GF Fund Management’s Jyong Biotech MENS Stock Holding History

GF Fund Management’s Portfolio MENS Stock Details MENS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.48K Buy
1,697
+138
+9% +$302 ﹤0.01% 588
2026
Q2 		$3.23K Sell
1,559
-118
-7% -$250 ﹤0.01% 584
2026
Q1 		$3.61K Buy
1,677
+184
+12% +$450 ﹤0.01% 612
2025
Q4 		$5.9K Buy
+1,493
New +$52.7K ﹤0.01% 615

Other funds holding MENS

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
StoneX Group
StoneX Group New York $2.75B AUM 24.13% 1-Year Est. Return
China Universal Asset Management Company
China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $57.1B AUM 43.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Cornerstone Financial Management
Cornerstone Financial Management Burlington, Massachusetts $128M AUM 13.18% 1-Year Est. Return
Bell Investment Advisors
Bell Investment Advisors Oakland, California $684M AUM 11.43% 1-Year Est. Return
Caitong International Asset Management
Caitong International Asset Management Hong Kong $1.04B AUM 150.26% 1-Year Est. Return

GF Fund Management's MENS Position: Q3 2026 in Review

GF Fund Management increased its Jyong Biotech (MENS) stake by 8.9% in Q3 2026, buying an estimated $302 and bringing the position to 1,697 shares worth $3.48K. The position accounts for ﹤0.01% of the portfolio, ranked #588.

GF Fund Management first reported a position in MENS in Q4 2025 and has held it in 4 quarters since. The position peaked at $5.9K in Q4 2025. 11 funds tracked by Wall St. Rank hold MENS as of Q3 2026.

  • GF Fund Management held 1,697 shares of Jyong Biotech worth $3.48K as of Q3 2026.
  • GF Fund Management bought 138 Jyong Biotech shares in Q3 2026, an estimated $302.
  • Jyong Biotech made up ﹤0.01% of GF Fund Management's portfolio in Q3 2026, its #588 holding.
  • GF Fund Management first reported a position in Jyong Biotech in Q4 2025 and has held it in 4 quarters since.
  • GF Fund Management's Jyong Biotech position peaked at $5.9K in Q4 2025.
  • 11 funds tracked by Wall St. Rank held Jyong Biotech as of Q3 2026.

Based on GF Fund Management's 13F filing for Q3 2026, filed 26 Oct 2026.